Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dolores Ibarreta

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Personalized Medicine|May 23, 2018
InterviewDolores Ibarreta
Revista De Derecho Y Genoma Humano = Law and the Human Genome Review|May 19, 2010
Data protection in biobanks--a European challenge for the long-term sustainability of biobankingTobias Schulte in den Baumen, Daniele Paci, Dolores Ibarreta
Nature|March 28, 2009
The phantom menace of gene patentsSibylle Gaisser, Michael M Hopkins, Kathleen Liddell, et al.
Nature Biotechnology|October 8, 2004
Towards quality assurance and harmonization of genetic testing services in the European UnionDolores Ibarreta, Robert Elles, Jean-Jacques Cassiman, et al.
Personalized Medicine|May 23, 2018
TPMT testing in azathioprine: a 'cost-effective use of healthcare resources'?Katherine Payne, William G Newman, David Gurwitz, et al.
Pharmacogenomics|June 4, 2008
Sample, data use and protection in biobanking in Europe: legal issuesEleni Zika, Tobias Schulte In den Bäumen, Jane Kaye, et al.
International Journal of Technology Assessment in Health Care|July 8, 2008
Avoiding adverse drug reactions by pharmacogenetic testing: a systematic review of the economic evidence in the case of TPMT and AZA-induced side effectsAmelia Compagni, Simona Bartoli, Bernhard Buehrlen, et al.
Molecular Diagnosis & Therapy|October 30, 2007
Modeling the impact of genetic screening technologies on healthcare: theoretical model for asthma in childrenEmma Gutiérrez de Mesa, Ignacio Hidalgo, Panayotis Christidis, et al.
Environmental Health Perspectives|September 9, 2017
Adaptation to Climate Change: A Comparative Analysis of Modeling Methods for Heat-Related MortalitySimon N Gosling, David M Hondula, Aditi Bunker, et al.
Pharmacogenomics|April 21, 2009
CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studiesCristina Rodríguez-Antona, David Gurwitz, Jose de Leon, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Personalized Medicine|May 23, 2018
InterviewDolores Ibarreta
Revista De Derecho Y Genoma Humano = Law and the Human Genome Review|May 19, 2010
Data protection in biobanks--a European challenge for the long-term sustainability of biobankingTobias Schulte in den Baumen, Daniele Paci, Dolores Ibarreta
Nature|March 28, 2009
The phantom menace of gene patentsSibylle Gaisser, Michael M Hopkins, Kathleen Liddell, et al.
Nature Biotechnology|October 8, 2004
Towards quality assurance and harmonization of genetic testing services in the European UnionDolores Ibarreta, Robert Elles, Jean-Jacques Cassiman, et al.
Personalized Medicine|May 23, 2018
TPMT testing in azathioprine: a 'cost-effective use of healthcare resources'?Katherine Payne, William G Newman, David Gurwitz, et al.
Pharmacogenomics|June 4, 2008
Sample, data use and protection in biobanking in Europe: legal issuesEleni Zika, Tobias Schulte In den Bäumen, Jane Kaye, et al.
International Journal of Technology Assessment in Health Care|July 8, 2008
Avoiding adverse drug reactions by pharmacogenetic testing: a systematic review of the economic evidence in the case of TPMT and AZA-induced side effectsAmelia Compagni, Simona Bartoli, Bernhard Buehrlen, et al.
Molecular Diagnosis & Therapy|October 30, 2007
Modeling the impact of genetic screening technologies on healthcare: theoretical model for asthma in childrenEmma Gutiérrez de Mesa, Ignacio Hidalgo, Panayotis Christidis, et al.
Environmental Health Perspectives|September 9, 2017
Adaptation to Climate Change: A Comparative Analysis of Modeling Methods for Heat-Related MortalitySimon N Gosling, David M Hondula, Aditi Bunker, et al.
Pharmacogenomics|April 21, 2009
CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studiesCristina Rodríguez-Antona, David Gurwitz, Jose de Leon, et al.
Pageof 3